3. A cardiologist prescribes a patient a new ACE inhibitor within the context of a clinical trial. The patient already has chronic kidney failure. The GP considers checking the suitability of the medication to be entirely the responsibility of the cardiologist and therefore takes no action. Here, ACE is linked to chronic renal failure syndrome.